Mother-baby drug to be phased out as single therapy
The Medicines Control Council, has recommended to the Health Ministry that it stop using nevirapine as a single agent in the prevention of mother-to-child-HIV-transmission. Health-e caught up with the Registrar of medicines Precious Matsoso, at the XV International AIDS
Conference in Bangkok, Thailand, and asked her why the MCC made the decision.







